591 results on '"Sheikh A"'
Search Results
2. Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile
3. 5 PS: OPOSSUM BITE CAUSING PURULENT PERICARDITIS LEADING TO PERICARDIAL TAMPONADE SECONDARY TO PASTEURELLA MULTOCIDA
4. TRILOGY OF HEMOPTYSIS, PNEUMOTHORAX, AND PNEUMATOCELE ASSOCIATED WITH NONINVASIVE POSITIVE PRESSURE VENTILATION
5. INPATIENT UTILIZATION OF SEPSIS PATHWAY AND ITS IMPACT ON THE LENGTH OF STAY AMONG THE PATIENTS DIAGNOSED WITH SEPSIS, SEVERE SEPSIS, AND SEPTIC SHOCK
6. SPONTANEOUS HEMORRHAGIC PERICARDIAL TAMPONADE: A RARE AND UNDERRECOGNISED COMPLICATION IN END-STAGE RENAL DISEASE PATIENTS DEPENDENT ON DIALYSIS
7. IMPACT OF ELEXACAFTOR-TEZACAFTOR-IVACAFTOR (ETI) ON LUNG DISEASE IN PATIENTS WITH CYSTIC FIBROSIS
8. INPATIENT UTILIZATION OF SEPSIS PATHWAY AND ITS IMPACT ON THE MORTALITY AMONG THE PATIENTS WITH SEPTIC SHOCK
9. QUALITY OF LIFE ASSESSMENT IN CHILDREN WITH SLEEP-DISORDERED BREATHING
10. A RARE PRESENTATION OF SEVERE CAVITARY PNEUMONIA BY STENOTROPHOMONAS MALTOPHILIA IN IMMUNOCOMPROMISED PATIENT WITH PULMONARY HISTOPLASMOSIS
11. INFECTIVE ENDOCARDITIS PRESENTING AS DIFFUSE ALVEOLAR HEMORRHAGE
12. UNEXPECTED TWISTS: DISCOVERING PARTIAL ANOMALOUS PULMONARY VENOUS RETURN DURING A ROUTINE LEFT INTERNAL JUGULAR DIALYSIS CATHETER INSERTION
13. VENTILATOR-ASSOCIATED TRACHEOBRONCHITIS PRESENTING AS RECURRENT PNEUMONIA
14. INFLAMMATION IN ACUTE ASTHMA: INNATE IMMUNE RESPONSES
15. RESPIRATORY FAILURE AND ESOPHAGEAL DILATION: A CASE REPORT
16. A CASE OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS INDUCED BY ACUTE HUMAN IMMUNODEFICIENCY VIRUS INFECTION
17. IMPACT OF ELEXACAFTOR-TEZACAFTOR-IVACAFTOR (ETI) ON CHRONIC SINUS DISEASE IN PATIENTS WITH CYSTIC FIBROSIS
18. MULTI-DRUG RESISTANT FUNGEMIA, A FIRST CASE IN NEW MEXICO
19. CEREBRAL AIR EMBOLISM WITH INTRA-PLEURAL FIBRINOLYTIC THERAPY
20. Cardiovascular Complications Are the Primary Drivers of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia
21. Response
22. A NOVEL SIMULATION-BASED EDUCATIONAL CURRICULUM TO BRIDGE THE GAP BETWEEN SEPSIS AND POSTSEPSIS CARE.
23. IMPACT OF SEVERITY OF LUNG DISEASE ON EFFICACY OF ELEXACEFTOR-TEZACEFTOR-IVACEFTOR (ETI) IN CYSTIC FIBROSIS.
24. HYPERSOMNIA IN THE INTENSIVE CARE UNIT: A MARKER FOR POOR OUTCOMES?
25. GRAVID FEMALE DEVELOPS TRUE CHYLOUS EFFUSION IN THE SETTING OF LATENT TUBERCULOSIS.
26. EFFECT OF CATHETER-DIRECTED THROMBOLYSIS OR CATHETER-DIRECTED EMBOLECTOMY ON PULMONARY ARTERY PRESSURES IN INTERMEDIATE- AND HIGH-RISK PULMONARY EMBOLISM.
27. METAPNEUMOVIRUS ASSOCIATED ATYPICAL HEMOLYTIC UREMIC SYNDROME.
28. A 40-Year-Old Man With Respiratory Failure and Sepsis
29. Cardiovascular Complications Are the Primary Drivers of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia
30. IMPACT OF CFTR MODULATOR THERAPY (ELEXACAFATOR/TEZACAFTOR/IVACAFTOR) ON METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AND FUNGAL COLONIZATION AND INFLAMMATION IN CYSTIC FIBROSIS
31. USE OF INHALED TREPROSTINIL IN PULMONARY HYPERTENSION AND COPD
32. ANTISYNTHETASE SYNDROME PRESENTING AS INTERSTITIAL LUNG DISEASE: A CASE OF ANCHORING BIAS DURING THE COVID-19 PANDEMIC
33. PSEUDOMONAS AERUGINOSA COSTOCHONDRITIS ASSOCIATED WITH RECENT IV DRUG USE
34. IMPACT OF CFTR MODULATOR THERAPY (LEXACAFTOR/TEZACAFTOR/IVACAFTOR) ON PSEUDOMONAL COLONIZATION AND INFLAMMATION IN CYSTIC FIBROSIS
35. IMPACTS OF THE COVID-19 PANDEMIC ON THE MENTAL HEALTH OF HOUSE STAFF
36. DELAYED ASPIRATION THROMBECTOMY OF SADDLE PULMONARY EMBOLISM IN A HEMODYNAMICALLY STABLE PATIENT
37. IMPACT OF PREVIOUS EXPOSURE TO CFTR MODULATORS ON EFFICACY OF ELEXACAFTOR-TEZACAFTOR-IVACAFTOR (ETI) IN CYSTIC FIBROSIS
38. EUSTACHIAN VALVE ENDOCARDITIS: A CLINICAL-CHALLENGING ENTITY
39. ACUTE INTERSTITIAL PNEUMONIA SECONDARY TO AMIKACIN LIPOSOME INHALATION SUSPENSION
40. DISSEMINATED BLASTOMYCOSIS AND RESPIRATORY FAILURE IN A RENAL TRANSPLANT PATIENT
41. IMPACT OF ATYPICAL N3 SLEEP PATTERN ON PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT
42. IMPACT OF A PHARMACIST-DRIVEN PREAPPROVAL PROCESS FOR PARENTERAL PULMONARY ARTERIAL HYPERTENSION THERAPIES ON HOSPITAL LENGTH OF STAY
43. OUTCOMES FOLLOWING CATHETER-DIRECTED THROMBOLYSIS AND CATHETER-DIRECTED EMBOLECTOMY IN INTERMEDIATE AND HIGH-RISK PULMONARY EMBOLISM
44. A UNIQUE AND CHALLENGING PRESENTATION OF METASTATIC DUCTAL CARCINOMA OF BREAST AS INTERSTITIAL LUNG DISEASE
45. DAPTOMYCIN-INDUCED EOSINOPHILIC PNEUMONITIS: EARLY RECOGNITION AND EMPIRIC STEROID THERAPY
46. MAN VS WILD: A UNIQUE CASE OF ACUTE PULMONARY SALMONELLOSIS
47. Response
48. IMPACT OF CFTR MODULATOR THERAPY (LEXACAFTOR/TEZACAFTOR/IVACAFTOR) ON PSEUDOMONAL COLONIZATION AND INFLAMMATION IN CYSTIC FIBROSIS
49. DELAYED ASPIRATION THROMBECTOMY OF SADDLE PULMONARY EMBOLISM IN A HEMODYNAMICALLY STABLE PATIENT
50. IMPACT OF CFTR MODULATOR THERAPY (ELEXACAFATOR/TEZACAFTOR/IVACAFTOR) ON METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AND FUNGAL COLONIZATION AND INFLAMMATION IN CYSTIC FIBROSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.